Panelists
- Tarun Khanna, Jorge Paulo Lemann Professor, Harvard Business School & Director, Lakshmi Mittal and Family South Asia Institute, Harvard University
- Gagandeep Kang, Executive Director, Translational Health Science and Technology Institute & Vice Chairperson of The Coalition for Epidemic Preparedness Innovations
- Umang Vohra, Managing Director & Global Chief Executive Officer, Cipla Ltd.
- David E. Bloom, Clarence James Gamble Professor of Economics & Demography, Harvard T.H. Chan School of Public Health
Through the lens of a contemporary case study, Harvard Business School Professor Tarun Khanna will share the geo-politics of how vaccines are developed, the funding and distribution methods that are critical to the effort, and the global alliances that facilitate this in the world today. He will speak with Dr. Gagandeep Kang, Executive Director, Translational Health Science and Technology Institute & Vice Chairperson of The Coalition for Epidemic Preparedness Innovations; Umang Vohra, Managing Director & Global Chief Executive Officer, Cipla Ltd, and Dr. David E. Bloom, Clarence James Gamble Professor of Economics & Demography, Harvard T.H. Chan School of Public Health, in a discussion on the South Asia context.
The objective is to share the mechanics and commerce of vaccine development and the critical role that science and business can play in combating pandemics such as COVID-19. The intent is to foster a collaborative and synchronous effort among science, business, and government to find synergies and solutions as they navigate the current challenges. How does one forge worldwide alliances in healthcare? How can science, business, government, and society collaborate on healthcare imperatives? How does one resolve the logistics and equity of vaccine distribution, and how can credibility and trust be built? This interactive conversation will be presented via Zoom web-conference.
